[{"id":"FT575894","type":"mcq","stimulusHtml":"<p>Type 1 diabetes results from the destruction of insulin-producing cells in the pancreas. Individuals with type 1 diabetes produce insufficient amounts of insulin, a hormone that regulates the concentration of glucose in the blood.</p>\n\n<p>Which of the following best explains how treatment with a drug that stimulates the production of insulin receptors on target cells will affect the insulin signaling pathway in an individual with type 1 diabetes?</p>\n","choicesHtml":["<p>The drug will have little or no effect on the signaling pathway because the receptors will not be activated in the absence of insulin.</p>","<p>The drug will have little or no effect on the signaling pathway because insulin receptors will not be allowed to enter the cells.</p>","<p>The drug will restore the function of the signaling pathway because insulin levels will return to normal.</p>","<p>The drug will restore the function of the signaling pathway because nonpancreatic cells will begin to produce insulin receptors.</p>"],"answer":-1}]